From testing roughly 143,000 blood donors nationwide, the Centers for Disease Control and Prevention found that 77.5% of surveyed individuals had COVID-19 antibodies, from vaccines, the virus, or both, by the end of 2022.
This is the third lawsuit over the new Medicare program in which Bristol Myers' blood thinner Eliquis is expected to be one of the first 10 drugs subject to price negotiations.
A new report encourages large employers to support equity-focused programs — such as varying premium contributions based on salary — to potentially help reduce economic barriers to access among lower-wage workers.
The Telehealth Benefit Expansion for Workers Act would allow employers to offer workers standalone telehealth benefits, however, some detractors say it leaves employees unprotected from deceptive marketing practices.